{"id":17918,"date":"2018-03-12T11:44:36","date_gmt":"2018-03-12T10:44:36","guid":{"rendered":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/"},"modified":"2018-04-27T09:52:47","modified_gmt":"2018-04-27T08:52:47","slug":"la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/","title":{"rendered":"The European Commission publishes the opinion of its experts on financing models for innovative medicines"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Background<\/strong><\/p>\n<p style=\"text-align: justify;\">The Expert Panel on effective ways of investing in Health was created with the purpose of providing non-binding advice to the Commission on matters related to the efficacy, access and resilience of the healthcare systems.<\/p>\n<p style=\"text-align: justify;\">The report that we refer to, called \u201cInnovative payment models for high-cost innovative medicines\u201d, is interesting as it provides a general overview on some basic principles of the new financing models for innovative medicines.<\/p>\n<p style=\"text-align: justify;\"><strong>Opinion of the experts<\/strong><\/p>\n<p style=\"text-align: justify;\">The basic principles that according to the Expert Panel should prevail in the new financing models are the following ones:<\/p>\n<p style=\"text-align: justify;\">&#8211;\u00a0 It is advised that, for transparency purposes, pharmaceutical companies submit to the authorities an estimate of the costs that they have incurred regarding investigation.<\/p>\n<p style=\"text-align: justify;\">&#8211; The healthcare systems are encouraged to explore ways of protecting innovation out of the patent system and to provide mechanisms so that the public sector participates in the returns from the R&amp;D which it funds.<\/p>\n<p style=\"text-align: justify;\">&#8211; It is stated that there is not a single model to measure the value and the results of innovative medicines, but it is essential to increase comparability of the data, preferably across countries, as well as to improve remuneration for therapeutic value.<\/p>\n<p style=\"text-align: justify;\">&#8211; In the context of price negotiations, mechanisms should be introduced in order to control, through the competition authorities, situations of abusive market power.<\/p>\n<p style=\"text-align: justify;\">&#8211; It is considered that there in no model which can be used for all scenarios, but that different models must coexist and be used depending on the case.<\/p>\n<p style=\"text-align: justify;\">&#8211; It is pointed out that the purchase of integral solutions in health (services) is an alternative to the purchase of products, and it is considered that moving towards this direction will better compensate effective treatments.<\/p>\n<p style=\"text-align: justify;\">&#8211; Likewise, the creation of dialogue platforms which involve authorities and representatives of pharmaceutical companies is encouraged.<\/p>\n<p style=\"text-align: justify;\">The report of the Expert Panel is a tool of high value in the current context, and it synthesizes\u00a0 highly interesting ideas. However, in our opinion the report misses the chance of offering a clear support to the incorporation of the endless possibilities of Real World Evidence\u00a0to the mechanisms of measuring results in health. Big Data will certainly play a fundamental role in the decisions of price and reimbursement of medicinal products and other health interventions in\u00a0the\u00a0not-too-distant future.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Background The Expert Panel on effective ways of investing in Health was created with the purpose of providing non-binding advice to the Commission on matters related to the efficacy, access and resilience of the healthcare systems. The report that we refer to, called \u201cInnovative payment models for high-cost innovative medicines\u201d, is interesting as it provides&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\" class=\"excerpt-read-more\">Read More<\/a><\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[72,86,87],"tags":[],"coauthors":[],"class_list":["post-17918","post","type-post","status-publish","format-standard","hentry","category-capsulas-en","category-pharmaceutical-and-life-sciences-law","category-pricing-and-public-financing"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The European Commission publishes the opinion of its experts on financing models for innovative medicines - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The European Commission publishes the opinion of its experts on financing models for innovative medicines - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"Background The Expert Panel on effective ways of investing in Health was created with the purpose of providing non-binding advice to the Commission on matters related to the efficacy, access and resilience of the healthcare systems. The report that we refer to, called \u201cInnovative payment models for high-cost innovative medicines\u201d, is interesting as it provides... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-12T10:44:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-27T08:52:47+00:00\" \/>\n<meta name=\"author\" content=\"Merc\u00e8 Maresma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Merc\u00e8 Maresma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\"},\"author\":{\"name\":\"Merc\u00e8 Maresma\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/9b06a3741847fda133da58121f664fc2\"},\"headline\":\"The European Commission publishes the opinion of its experts on financing models for innovative medicines\",\"datePublished\":\"2018-03-12T10:44:36+00:00\",\"dateModified\":\"2018-04-27T08:52:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\"},\"wordCount\":403,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Capsulas\",\"Pharmaceutical and Life Sciences Law\",\"Pricing and Public Financing\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\",\"url\":\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\",\"name\":\"The European Commission publishes the opinion of its experts on financing models for innovative medicines - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2018-03-12T10:44:36+00:00\",\"dateModified\":\"2018-04-27T08:52:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The European Commission publishes the opinion of its experts on financing models for innovative medicines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/9b06a3741847fda133da58121f664fc2\",\"name\":\"Merc\u00e8 Maresma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/602b9f178f2f88f72961f4d54be9dbf0\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ce15166c954e3d4a56c3b4d253d69d547f3aafe0ddae4b65e68f50a68ce7329c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ce15166c954e3d4a56c3b4d253d69d547f3aafe0ddae4b65e68f50a68ce7329c?s=96&d=mm&r=g\",\"caption\":\"Merc\u00e8 Maresma\"},\"url\":\"https:\/\/faus-moliner.com\/en\/author\/merce-maresma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The European Commission publishes the opinion of its experts on financing models for innovative medicines - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/","og_locale":"en_US","og_type":"article","og_title":"The European Commission publishes the opinion of its experts on financing models for innovative medicines - Faus Moliner","og_description":"Background The Expert Panel on effective ways of investing in Health was created with the purpose of providing non-binding advice to the Commission on matters related to the efficacy, access and resilience of the healthcare systems. The report that we refer to, called \u201cInnovative payment models for high-cost innovative medicines\u201d, is interesting as it provides... Read More","og_url":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/","og_site_name":"Faus Moliner","article_published_time":"2018-03-12T10:44:36+00:00","article_modified_time":"2018-04-27T08:52:47+00:00","author":"Merc\u00e8 Maresma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Merc\u00e8 Maresma","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/"},"author":{"name":"Merc\u00e8 Maresma","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/9b06a3741847fda133da58121f664fc2"},"headline":"The European Commission publishes the opinion of its experts on financing models for innovative medicines","datePublished":"2018-03-12T10:44:36+00:00","dateModified":"2018-04-27T08:52:47+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/"},"wordCount":403,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Capsulas","Pharmaceutical and Life Sciences Law","Pricing and Public Financing"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/","url":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/","name":"The European Commission publishes the opinion of its experts on financing models for innovative medicines - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2018-03-12T10:44:36+00:00","dateModified":"2018-04-27T08:52:47+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/la-comision-europea-publica-la-opinion-expertos-modelos-financiacion-medicamentos-innovadores\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"The European Commission publishes the opinion of its experts on financing models for innovative medicines"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/9b06a3741847fda133da58121f664fc2","name":"Merc\u00e8 Maresma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/602b9f178f2f88f72961f4d54be9dbf0","url":"https:\/\/secure.gravatar.com\/avatar\/ce15166c954e3d4a56c3b4d253d69d547f3aafe0ddae4b65e68f50a68ce7329c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ce15166c954e3d4a56c3b4d253d69d547f3aafe0ddae4b65e68f50a68ce7329c?s=96&d=mm&r=g","caption":"Merc\u00e8 Maresma"},"url":"https:\/\/faus-moliner.com\/en\/author\/merce-maresma\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/17918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=17918"}],"version-history":[{"count":0,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/17918\/revisions"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=17918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=17918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=17918"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=17918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}